AbbVie (ABBV) Pays Out More Than It Earns. How Long Can That Hold?

insidermonkey.com · 2026-10-07

AbbVie Inc. (NYSE:ABBV) was trading at around $263 on October 5, up 14.18% over twelve months. Its payout ratio is 190.40%. The company distributes nearly twice what it reports as profit.

TickrTrends take: AbbVie's payout ratio exceeding earnings raises questions about the sustainability of its current dividend level and capital allocation strategy. Given TickrTrends' overvalued assessment, investors focused on valuation metrics should monitor whether the company can maintain its distributions through operating cash flow or if it will need to rely on asset sales or increased leverage. For a healthcare company trading at elevated valuations, any deterioration in earnings growth or free cash flow generation could pressure both the dividend and the stock price.

Read the full story at insidermonkey.com →